SEC Form 4 · accession 0001013606-16-000214
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shari L O'Quinn
Officer — VP, Clinical & Regulatory
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 12:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Feb 29, 2016 | J | 18,681 | $0.00 | A | 58,522 | D | |
| Common Shares | Feb 29, 2016 | S$0 | 4,000 | $0.00 | D | 54,522 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued relate to the exchange of TriVascular, Inc shares for Endologix, Inc shares per Endologix, Inc's agreement to acquire TriVascular, Inc.